CN114921420A - 一种鸭疫里氏杆菌噬菌体 - Google Patents
一种鸭疫里氏杆菌噬菌体 Download PDFInfo
- Publication number
- CN114921420A CN114921420A CN202210157641.2A CN202210157641A CN114921420A CN 114921420 A CN114921420 A CN 114921420A CN 202210157641 A CN202210157641 A CN 202210157641A CN 114921420 A CN114921420 A CN 114921420A
- Authority
- CN
- China
- Prior art keywords
- riemerella anatipestifer
- bacteriophage
- phage
- anatipestifer
- riemerella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001478212 Riemerella anatipestifer Species 0.000 title claims abstract description 96
- 241001515965 unidentified phage Species 0.000 claims abstract description 34
- 230000009089 cytolysis Effects 0.000 claims abstract description 18
- 241000894006 Bacteria Species 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 15
- 230000001580 bacterial effect Effects 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 210000002966 serum Anatomy 0.000 claims description 14
- 244000309466 calf Species 0.000 claims description 13
- 238000012258 culturing Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 239000001963 growth medium Substances 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 229920001817 Agar Polymers 0.000 claims description 6
- 241000272525 Anas platyrhynchos Species 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 238000009630 liquid culture Methods 0.000 claims description 6
- 239000012982 microporous membrane Substances 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 239000002609 medium Substances 0.000 claims description 4
- 230000007480 spreading Effects 0.000 claims description 4
- 238000003892 spreading Methods 0.000 claims description 4
- 210000003608 fece Anatomy 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000002689 soil Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 241000186781 Listeria Species 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 abstract description 10
- 230000004151 fermentation Effects 0.000 abstract description 10
- 238000001228 spectrum Methods 0.000 abstract description 10
- 238000012216 screening Methods 0.000 abstract description 8
- 238000002474 experimental method Methods 0.000 abstract description 5
- 238000000926 separation method Methods 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 238000005336 cracking Methods 0.000 description 18
- 206010058556 Serositis Diseases 0.000 description 8
- 241001478225 Riemerella Species 0.000 description 7
- 238000003776 cleavage reaction Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000002458 infectious effect Effects 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- 230000002101 lytic effect Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000272517 Anseriformes Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000518490 Riella Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10351—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210157641.2A CN114921420B (zh) | 2022-02-21 | 2022-02-21 | 一种鸭疫里氏杆菌噬菌体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210157641.2A CN114921420B (zh) | 2022-02-21 | 2022-02-21 | 一种鸭疫里氏杆菌噬菌体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114921420A true CN114921420A (zh) | 2022-08-19 |
CN114921420B CN114921420B (zh) | 2023-06-09 |
Family
ID=82805652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210157641.2A Active CN114921420B (zh) | 2022-02-21 | 2022-02-21 | 一种鸭疫里氏杆菌噬菌体 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114921420B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112646786A (zh) * | 2021-01-21 | 2021-04-13 | 海南海壹水产种苗有限公司 | 一株坎式弧菌噬菌体快速初步分离方法 |
CN117987378A (zh) * | 2024-02-01 | 2024-05-07 | 青岛润达生物科技有限公司 | 一株耐高温鸭疫里默氏杆菌噬菌体及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101575592A (zh) * | 2009-04-22 | 2009-11-11 | 福建省农业科学院畜牧兽医研究所 | 鸭疫里氏杆菌敏感的烈性噬菌体及应用 |
-
2022
- 2022-02-21 CN CN202210157641.2A patent/CN114921420B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101575592A (zh) * | 2009-04-22 | 2009-11-11 | 福建省农业科学院畜牧兽医研究所 | 鸭疫里氏杆菌敏感的烈性噬菌体及应用 |
Non-Patent Citations (3)
Title |
---|
CHENG等: "Complete genomic sequence of the virulent bacteriophage RAP44 of Riemerella anatipestifer.", AVIAN DISEASES * |
程龙飞等: "鸭疫里氏杆菌敏感烈性噬菌体的分离鉴定", 中国兽医科学 * |
钟敏等: "鸭疫里氏杆菌敏感烈性噬菌体RAP44的生物学特性", 中国兽医科学 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112646786A (zh) * | 2021-01-21 | 2021-04-13 | 海南海壹水产种苗有限公司 | 一株坎式弧菌噬菌体快速初步分离方法 |
CN117987378A (zh) * | 2024-02-01 | 2024-05-07 | 青岛润达生物科技有限公司 | 一株耐高温鸭疫里默氏杆菌噬菌体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN114921420B (zh) | 2023-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114921420B (zh) | 一种鸭疫里氏杆菌噬菌体 | |
CN113416712B (zh) | 一株宽裂解谱沙门氏菌噬菌体及其应用 | |
CN114561363B (zh) | 一种具有跨种裂解能力的弧菌噬菌体PC-Liy1、制备方法及应用 | |
CN113293143B (zh) | 一株可降低鸡白痢沙门氏菌垂直传播的沙门氏菌噬菌体及其应用 | |
CN113583966B (zh) | 一株烈性沙门氏菌噬菌体及其应用 | |
CN114045268A (zh) | 一种防治植保青枯雷尔氏菌、青枯假单胞菌病害的噬菌体及其应用 | |
CN111057681B (zh) | 一株噬菌体及其应用 | |
CN114958779B (zh) | 一株能够裂解产气荚膜梭菌的噬菌体lpcpa6及应用 | |
CN113444695B (zh) | 一株发酵效率高且临床效果好的大肠杆菌噬菌体及其应用 | |
CN113061550B (zh) | 一株乳杆菌新菌株z6及其在食品中的应用 | |
CN115927205A (zh) | 一株跨种属裂解型肺炎克雷伯菌噬菌体及其用途 | |
CN114703149A (zh) | 一株高发酵率、抑菌持久的溶藻弧菌噬菌体gva-p21及其应用 | |
CN113444693B (zh) | 一种噬菌体与益生菌的联合发酵工艺 | |
CN114921419B (zh) | 一种鸭疫里氏杆菌噬菌体 | |
CN118147090B (zh) | 一株同时裂解多株大肠杆菌和沙门氏菌的噬菌体及其应用 | |
CN113215111B (zh) | 一种噬菌体及在防治肉鸡心内膜炎中的医用用途 | |
CN115418355B (zh) | 一种迟缓葡萄球菌噬菌体及其分离方法与应用 | |
CN115851617B (zh) | 一种大肠杆菌噬菌体lhe83及其应用 | |
CN116042541A (zh) | 一种溶藻弧菌噬菌体grnrz-p25及其应用 | |
CN114958778B (zh) | 一株副溶血弧菌裂解性噬菌体gvp-p20及其在中华绒螯蟹中副溶血弧菌的防治应用 | |
CN118147090A (zh) | 一株同时裂解多株大肠杆菌和沙门氏菌的噬菌体及其应用 | |
CN118272319A (zh) | 一种精准防控阪崎克罗诺杆菌和生物膜的噬菌体及噬菌体制剂的制备方法 | |
CN117070471A (zh) | 一株可口服进入血液的多价沙门氏菌噬菌体及其应用 | |
CN117887674A (zh) | 一株弯曲菌噬菌体vB Ca61 2022及其培养方法和应用 | |
CN116948986A (zh) | 一种抗细菌耐受的多价溶藻弧菌噬菌体vap230304及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240124 Address after: 1 / F and 2 / F, building 4, banglun Pharmaceutical Industrial Park, 390 Gaoxin 2nd Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430000 Patentee after: Wuhan grenon Biotechnology Co.,Ltd. Country or region after: China Address before: 430000 No.1 Shizishan street, Hongshan District, Wuhan City, Hubei Province Patentee before: HUAZHONG AGRICULTURAL University Country or region before: China |
|
TR01 | Transfer of patent right |